Fredag 28 November | 01:30:26 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-11-26 07:20 Kvartalsrapport 2026-Q3
2026-08-25 07:20 Kvartalsrapport 2026-Q2
2026-05-27 07:20 Kvartalsrapport 2026-Q1
2026-03-25 N/A Årsstämma
2026-02-25 07:00 Bokslutskommuniké 2025
2025-11-27 - Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-28 - Kvartalsrapport 2025-Q1
2025-03-28 - X-dag ordinarie utdelning FLUO 0.00 DKK
2025-03-27 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-11-27 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-30 - Kvartalsrapport 2024-Q1
2024-03-21 - X-dag ordinarie utdelning FLUO 0.00 DKK
2024-03-20 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-11-29 - Kvartalsrapport 2023-Q3
2023-08-30 - Kvartalsrapport 2023-Q2
2023-05-31 - Kvartalsrapport 2023-Q1
2023-03-22 - X-dag ordinarie utdelning FLUO 0.00 DKK
2023-03-21 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-31 - Kvartalsrapport 2022-Q1
2022-05-19 - X-dag ordinarie utdelning FLUO 0.00 DKK
2022-05-18 - Årsstämma
2022-03-30 - Bokslutskommuniké 2021
2021-11-24 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-05-26 - Kvartalsrapport 2021-Q1
2021-05-03 - X-dag ordinarie utdelning FLUO 0.00 DKK
2021-02-26 - Bokslutskommuniké 2020
2021-02-09 - Årsstämma
2020-11-20 - Kvartalsrapport 2020-Q3
2020-08-14 - Kvartalsrapport 2020-Q2
2020-05-27 - Kvartalsrapport 2020-Q1
2020-04-09 - X-dag ordinarie utdelning FLUO 0.00 DKK
2020-04-08 - Årsstämma
2020-02-28 - Bokslutskommuniké 2019
2019-11-29 - Kvartalsrapport 2019-Q3
2019-05-31 - Kvartalsrapport 2019-Q1

Beskrivning

LandDanmark
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
FluoGuide är ett danskt bolag verksamt inom medicinteknik. Bolaget affärsfokus återfinns inom forskning och utveckling av behandlingar mot olika cancerformer, med störst fokus på utveckling av produkter som vägleder vid kirurgiska ingrepp. Produkterna binder till sig cancercellerna som då lyser upp och är avsedda att användas för att med precision kunna ta bort skadliga tumörer i patientens vävnad.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-11-24 16:14:00

Copenhagen, Denmark, 24 November 2025 – FluoGuide A/S (“FluoGuide” or the “Company” held an extraordinary general meeting on 24 November 2025.

To the shareholders of FluoGuide A/S.
 
The Extraordinary General Meeting was held Monday 24 November 2025 at 10:00 AM (CET) at the Company’s premises Titangade 13B, DK-2200 Copenhagen N, Denmark.
 
Notice: Represented at the annual general meeting was share capital of nominal DKK 598,898.90 corresponding to 5,988,989 votes and 36.6% of the Company’s registered share capital.
 
The agenda for the Extraordinary General Meeting was as follows:
 
1. ELECTION OF CHAIRMAN OF THE MEETING
2. PROPOSALS FROM THE BOARD OF DIRECTORS AND SHAREHOLDERS
2.1 Election of new member of the board of directors
2.2 Authorisation to the board of directors to increase the share capital without pre-emptive rights for the shareholders
3. PROPOSAL TO AUTHORISE THE CHAIRMAN OF THE MEETING
4. MISCELLANEOUS
 
Adoptions:
 
Re 1: Election of chairman of the meeting
 
The board of directors proposed that attorney-at-law Lars Lüthjohan was elected as the chairman of the general meeting.
                
Lars Lüthjohan was elected as the chairman of the meeting unanimously with all votes present.
 
The chairman of the meeting stated, with the unanimous consent of the general meeting, that the general meeting was lawfully convened and legally competent to resolve upon the following agenda:
 
Re 2: Proposals from the board of directors
 
Re 2.1: Election of new member of the board of directors
 
Donna Haire resigned as a member of the board of directors as of 24 November 2025 as she has taken up a position as Chief Operating Officer in the Company.
 
The board of directors proposed Camilla Harder Hartvig as a new member of the board of directors.
 
Camilla Harder Hartvig was elected as new member of the board of directors unanimously with all votes present.
 
Re 2.2: Proposal to reestablish the authorisation to the board of directors to increase the share capital without pre-emptive rights for the shareholders
 
The board of directors proposed to reestablish the authorisation to increase the share capital without pre-emptive rights, cf. articles of association clause 3.3.1, by nominal DKK 272,916.40, from nominal DKK 27,083.60 to nominal DKK 300,000, the rest of the wording in the section should remain.
 
New clause 3.3.8 shall have the following wording:
 
“On 24 November 2025 the extraordinary general meeting increased the authorization from nominal DKK 27,083.60, cf. clause 3.3.7, to nominal DKK 300,000. Further reference is made to the above clauses 3.3.1 and 3.3.2.”
 
The general meeting resolved the proposal set forth above unanimously with all votes present.
 
Re 3: Proposal to authorise the chairman of the meeting
 
The board of directors proposed to authorise the chairman of the meeting (with a right of substitution) on behalf of the Company to apply the Danish Business Authority for registration of the resolutions passed by the general meeting and in this connection to make any such amendments to the documents prepared for such resolutions that may be required for registration with the Danish Business Authority.
 
The proposal was adopted by the general meeting unanimously with all votes present.
 
Re 4: Miscellaneous
 
Nothing to note in the minutes.
 
The general meeting adjourned.